Results 181 to 190 of about 4,504,355 (205)

Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis

New England Journal of Medicine, 2012
Ronald van Vollenhoven, Gene Wallenstein, Roy Fleischmann   +2 more
exaly  

Treatment of Rheumatoid Arthritis by Selective Inhibition of T-Cell Activation with Fusion Protein CTLA4Ig

New England Journal of Medicine, 2003
Joel M Kremer, Rieke Alten, Paul Emery
exaly  

Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis

New England Journal of Medicine, 2020
Maureen Rischmueller, Ricardo Machado Xavier, Andrea Rubbert-Roth   +2 more
exaly  

Anti-Cyclic Citrullinated Peptide ( ACCP ) Antibody versus Rheumatoid Factor ( RF ) for Diagnosis of Rheumatoid Arthritis

Egyptian Journal of Medical Microbiology, 2012
Mamdouh M. Esmat, Hoda M. Moghazy, Ahmed M. Boghdady   +2 more
openaire   +1 more source

Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three Medications

New England Journal of Medicine, 1996
James R O'Dell, James R O’Dell
exaly  

Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis

New England Journal of Medicine, 2004
Paul Emery, Jonathan Edwards, Randall M Stevens   +2 more
exaly  

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

New England Journal of Medicine, 1997
Roy Fleischmann, Larry Moreland, Michael H Schiff   +2 more
exaly  

Association of the B-Cell Alloantigen DRw4 with Rheumatoid Arthritis

New England Journal of Medicine, 1978
P Stastny
exaly  

[The rheumatoid factor (RF, rheuma factor, agglutination activating factor, RA factor)].

Suvremenna meditsina, 1998
V, TSONCHEV, N, POPOV
openaire   +1 more source

Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis

New England Journal of Medicine, 2001
Ernest Choy, Gabriel S Panayi
exaly